As a healthcare entrepreneur and investment strategist with over 25 years of experience, Jim Tananbaum came up with the idea for Foresite, which is a company that offers information, capital, and networks to entrepreneurs and financiers who want to create healthcare products. To-date, Foresite has invested in 77 healthcare companies and among them are Intarcia Therapeutics, 10x Genome, Aerie Pharmaceuticals, and more. His typical day consists of working with his team on existing portfolio company updates, new company presentations as well as networking with healthcare influencers. After work, Jim spends time with friends and family and squeezes an hour workout into each day.
Jim Tananbaum believes in funding the future of healthcare by helping individuals get the means to solve the largest health issues of the time. He believes that, for himself, his love to learn more drives his entrepreneurial spirit and keeps him motivated to help others and that without team synergy it’s hard to do good work. If Jim could go back in time and give himself advice, he would tell his younger self to have more faith in his own abilities. He believes that some of his strongest assets are to innovate and that he has listened to and followed the traditional way of doing things too much. Instead, if he had a chance to do it over, he would march to the beat of his own drum more.
In his Linked In profile, as the founder and CEO of Foresite Capital, Jim Tananbaum was an electrical engineering/computer science and math major at Yale who received his M.D. and M.B.A. from
Harvard and an M.S. from the Massachusetts Institute of Technology. He has a long history of leadership in the biopharmaceutical industry and believes our planet is entering a time of growth and amazing change that will be pushed forward by science. Before creating Foresite Capital, Jim founded GelTex Pharmaceuticals, which was purchased in 1998 for $1.6 billion during the same time that its top drug was producing a over $200 million in revenue on a yearly basis. He also co-founded and acted as CEO for Theravance, which when combined with its spinoff company, Theravance Biopharma, Inc., are worth a total of $3.2 billion. Visit the website, officialjimtananbaum.com.